The clinical study on the treatment of peptic ulcer with blood clot and drug intervention in the department of internal medicine
10.3969/j.issn.1005-1678.2017.04.142
- VernacularTitle:消化性溃疡黏附血凝块给予内镜干预与内科药物干预的临床研究
- Author:
Jinyue LI
;
Junyue TAO
;
Bin LI
;
Zhiming XU
;
Yuehong MA
- Keywords:
peptic ulcer;
blood clot;
esomeprazole;
endoscopy
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(4):432-434
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the clinical effect of drug intervention on the treatment of peptic ulcer with blood clots in the Department of internal medicine.Methods From 62 cases of peptic ulcer adherent blood clot were randomly divided into study group and control group according to the random number table,31 cases in each group,in each group.The control group was treated with esomeprazole infusion and subsequent oral treatment.The study group was given endoscopic hemostasis and subsequent oral esomeprazole treatment.Compare the two groups of curative effect,treatment profile and treatment before and after the study of the changes in the situation.Results The total effective rate of the study group was 90.32％,which was significantly better than that of the control group(P<0.05),which was significantly better than that of the control group 70.97％.Research group of rebleeding rate and transfer rate of surgery was significantly lower than that of control group(P<0.05),the study group,the time of hemostasis,the time of hospitalization significantly faster than that of the control group(P<0.05),study group medical expenses are significantly less than the control group(P<0.05).The two groups before treatment Blatchford score,Rockall score,SF-36 score no significant difference,after treatment in the two groups of the three scores were compared with those before treatment significantly optimized(P<0.05)study group the score optimization was significantly better than the control group(P<0.05).Conclusion Peptic ulcer adhesion blood clot give endoscopic therapy can greatly enhance the efficacy,reduce bleeding and transfer the risk of surgery,more effectively improve the acute upper digestive tract bleeding symptoms and signs,improve the life quality of the patients.
